Blood Pressure :: Genes and drugs team up to lower blood pressure

Patients with high blood pressure respond very differently to anti-hypertensive medication, making treatment selection tricky for physicians. But new research published in the online open access journal, BMC Medical Genetics, pinpoints a number of gene-drug interactions that could allow medication to be tailored to individual patients based on their genetics.

Contraceptive :: Contraceptive pill may reduce cancer risk

Taking the contraceptive pill does not increase a woman’s chances of developing cancer and may even reduce the risk for most women, according to a study published on bmj.com today. However there was an increased risk for women who used it for more than eight years.

Diabetes :: Long-term use of diabetes drug increases heart attack risk by more than 40 percent

An analysis of four studies involving more than 14,000 patients found that long-term use of the diabetes drug rosiglitazone (Avandia) increased the risk of heart attack by 42 percent and doubled the risk of heart failure, according to a new report from researchers at Wake Forest University School of Medicine and colleagues. There was no effect on death from cardiovascular causes.

Diabetes :: Takeda statement on ACTOS meta-analysis published in the Journal of the American Medical Association

Takeda Pharmaceuticals North America, Inc. is aware of the review of ACTOS (pioglitazone HCl) data conducted by A. Michael Lincoff, M.D., and colleagues at the Cleveland Clinic, published in the Journal of the American Medical Association, which concluded that ACTOS is associated with a significantly lower risk of heart attack, stroke or death among a diverse population of 16,390 patients with diabetes versus control therapy.

Cancer :: Study links education to risk of cancer death

A new American Cancer Society study finds having at least some education beyond high school is associated with a decreased risk of cancer death. The study finds higher education levels were strongly associated with decreased cancer mortality among black men, white men, and white women.

Glaucoma :: Glaucoma surgery in the blink of an eye

Prof. Ehud Assia, of Tel Aviv University?s Sackler School of Medicine is, quite simply, a rock star in the field of eye surgery. One of a small number of surgeons in the world who currently perform a complicated form of glaucoma surgery, Prof. Assia has developed a novel laser device that promises to revolutionize treatment of the disease.

Dr. Anil Singhal Homeopathic Doctor | Dr. Anil Singhal's Blog | Manan - My Memoir by Dr. Anil Singhal | Boger's Legacy | Organon of Medicine | Health Newstrack